Article
Linoleic acid derivatives target miR-361-3p/BTG2 to confer anticancer effects in acute myeloid leukemia
2022-05-18
Abstract excerpt
Acute myeloid leukemia (AML) is a deadly hematologic malignancy. Studies have shown that miroRNAs (miRNAs), evolutionarily conserved small noncoding RNAs, contribute to AML disease development, suggesting that therapeutical manipulation of miRNAs may benefit disease treatment in AML. In this study, we found miR-361-3p was significantly upregulated in the blood of AML patients, whereas the expression of its direct...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54550179-2ead-5534-b539-dbbb2fcc08bf
- DOI
- 10.21203/rs.3.rs-1653423/v1
